Voglipure 0.2mg Tablet
Marketer
Xenon Pharmaceuticals
Salt Composition
Voglibose (0.2mg)
Overview Voglipure 0.2mg Tablet
Glimepiride 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (high blood sugar after meals). It's employed when dietary modifications and other similar treatments prove insufficient in controlling elevated blood glucose. Administer Glimepiride 0.2mg just prior to meals. Dosage and frequency are determined individually by your physician to optimize blood sugar control. Discontinue use only under medical supervision; abrupt cessation may elevate blood sugar, risking serious complications including renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Common side effects may include gas, abdominal discomfort, appetite reduction, constipation, and diarrhea. Report any persistent or troublesome side effects to your physician. While Glimepiride itself doesn't cause hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Hypoglycemic episodes require treatment with pure glucose; table sugar is ineffective in this context. Inform your doctor of any kidney or liver conditions before starting treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all other medications to ensure safe and effective treatment. Limit alcohol consumption to minimize the potential for hypoglycemia.
Uses of Voglipure 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Voglipure 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglipure 0.2mg tablets should be administered on an empty stomach.
Common Side effects of Voglipure 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglipure 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglipure 0.2mg tablets should be taken on an empty stomach.
How Voglipure 0.2mg Tablet works:
Glucovance 0.2mg tablets are used to manage diabetes. By blocking the enzymes in the intestines that digest complex carbohydrates, they reduce the rapid post-meal surge in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglipure 0.2mg Tablet with alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
The use of Voglipure 0.2mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nonetheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Voglipure 0.2mg tablets appear compatible. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglipure 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglipure 0.2mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Voglipure 0.2mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglipure 0.2mg Tablet :
Omit any missed Voglipure 0.2mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglipure 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently